About Translumina Therapeutics LLP
Data last updated:
Translumina Therapeutics LLP was a limited liability partnership (LLP) based in New Delhi, Delhi, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 01 December 2009.
The LLP was registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAA-0435. Its GSTIN is 05AAGFT2436H1ZB (Uttarakhand). The LLP held 4 GST registrations, of which 3 are active.
The LLP had a total obligation of contribution of ₹1.01 Lakh. It was led by designated partners including Vishal Sharma and Indranil Mukherjee.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office was at Ground Floor Metro Tower Lsc Mor Land New Rajinder Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹375.69 Cr, a growth of 39% compared to the previous year. For the same year it recorded EBITDA of ₹2.29 Cr (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 21% over five years.
The LLP has about 363 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Translumina. As per MCA filings, the LLP has open charges of ₹60.95 Cr and satisfied charges of ₹9.25 Cr on record. Court records list 32 cases involving the LLP, including 13 filed by the LLP and 19 filed against it; 2 cases are pending.
The last known website on record is translumina.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Apps
- Registered AddressGround Floor Metro Tower Lsc Mor Land New Rajinder Nagar, New Delhi, Delhi, India – 110060
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands
Translumina Therapeutics operates one associated brand: Translumina. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards. | translumina.com |
Financials of Translumina Therapeutics LLP
FY 2024 filings availableTranslumina Therapeutics LLP reported revenue of ₹375.69 Cr (up 39% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 39% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2018-19 to FY 2021-22in the company report |
|---|---|---|
| Income and Expenditure | ||
| Turnover | •••• | |
| Other Income | •••• | |
| Total Income | •••• | |
| Purchases and Direct Costs | •••• | |
| Personnel Expenses | •••• | |
| Administrative Expenses | •••• | |
| Interest | •••• | |
| Depreciation | •••• | |
| Total Expenses | •••• | |
| Profit Before Tax | •••• | |
| Tax | •••• | |
| Profit After Tax | •••• | |
| Profit Transferred to Partners | •••• | |
| Assets and Liabilities | ||
| Partners' Contribution | •••• | |
| Reserves and Surplus | •••• | |
| Secured Loans | •••• | |
| Unsecured Loans | •••• | |
| Trade Payables | •••• | |
| Other Liabilities and Provisions | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Loans and Advances | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2018-19 to FY 2021-22in the company report |
|---|---|---|
| Profitability | ||
| Net Profit Margin | •••• | |
| Return on Partners' Funds | •••• | |
| Return on Assets | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Debt to Partners' Funds | •••• | |
| Interest Coverage | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Turnover Growth | •••• | |
| Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2018-19 to FY 2021-22, are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Translumina Therapeutics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Designated Partners of Translumina Therapeutics LLP
Translumina Therapeutics has 6 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
Peer Comparison
Translumina Therapeutics LLP is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nipro India Corporation Private Limited | ₹508.66 Cr (FY 2022) | •••• | •••• | 9.0% | •••• | Khandala, Maharashtra, India |
| Trivitron Healthcare Private Limited | ₹496.54 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Wipro Ge Medical Device Manufacturing Private Limited | ₹460.95 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Bangalore, Karnataka, India |
| Meril Diagnostics Private Limited | ₹443.81 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Vapi, Gujarat, India |
| Tarsons Products Limited Listed | ₹408.37 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Kolkata, West Bengal, India |
| Translumina Therapeutics LLP this company | ₹375.69 Cr (FY 2023) | •••• | •••• | 39.0% | •••• | New Delhi, Delhi, India |
| Dynamic Techno Medicals Private Limited | ₹375.5 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ernakulam, Kerala, India |
| Meril Endo Surgery Private Limited | ₹367.52 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vapi, Gujarat, India |
| Teleflex Medical Private Limited | ₹325.62 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Bengaluru, Karnataka, India |
| Veiva Scientific India Private Limited | ₹325.41 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Sensa Core Medical Instrumentation Private Limited | ₹320.78 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Pashamylaram, Telangana, India |
Peers are the companies nearest to Translumina Therapeutics by revenue, above and below it, in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding
: available in the company report
Charges & Borrowings
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2022 | Hdfc Bank Limited | ₹23 Lakh | Open |
| 30 Aug 2022 | Icici Bank Limited | ₹10 Cr | Open |
| 20 Apr 2022 | Hdfc Bank Limited | ₹16.06 Lakh | Open |
| 28 Jan 2022 | Hdfc Bank Limited | ₹50 Cr | Open |
| 27 Nov 2021 | Hdfc Bank Limited | ₹7.97 Lakh | Open |
Total charge records: 8 View all charges
Legal Cases
Translumina Therapeutics LLP has 32 court cases on record: 13 filed by Translumina Therapeutics, 19 filed against it. 2 cases are pending and 30 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 14 | 2 |
| NCLT | 4 | 0 | 0 |
| NCLAT | 4 | 4 | 0 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Principal Bench | Insolvency matter | Filed by the company against Metro Mas Hospital Private Limited | Disposed |
| NCLT, Chandigarh | Insolvency matter | Filed by the company against Akna Medical Private Limited | Disposed |
| NCLT, New Delhi Bench Court-III | Insolvency matter | Filed by the company against Medeor Hospital Limited | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against Saira Lifecare Pvt. Ltd. | Disposed |
| District court, Jalandhar, Punjab | Civil suit | Filed by the company against Oxford Hospitals Private Ltd | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Translumina Therapeutics LLP has a workforce of 363 employees as of Feb 08, 2025.
: available in the company report
Recent Activity
Translumina Therapeutics LLP has 8 designated partner changes on record since 2009: 6 appointments and 2 cessations. The latest: Indranil Mukherjee was appointed as Designated Partner on 15 Mar 2024.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Translumina Therapeutics has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGFT2436H1ZB | Uttarakhand | Active | 01 Jul 2017 |
| 07AAGFT2436H2Z6 | Delhi | Active | 01 Jul 2017 |
| 08AAGFT2436H1Z5 | Rajasthan | Active | 16 Feb 2022 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Translumina Therapeutics has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Translumina Therapeutics was a limited liability partnership based in New Delhi, Delhi, India. The LLP worked in medical and laboratory equipment, within the healthcare industry. It was incorporated on 01 December 2009 and is registered under LLPIN AAA-0435. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Translumina Therapeutics is AAA-0435. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Translumina Therapeutics had 6 designated partners:
- Vishal Sharma - Designated Partner
- Indranil Mukherjee - Designated Partner
- Gurmit Singh Chugh - Partner
- Avnish Mehra - Partner
- Punita Sharma - Designated Partner
- Vishal Omprakash Goenka - Designated Partner
Translumina Therapeutics was incorporated on 01 December 2009. It is registered with the Registrar of Companies, Delhi.
Translumina Therapeutics can be reached through the website translumina.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Translumina Therapeutics is at Ground Floor Metro Tower Lsc Mor Land New Rajinder Nagar, New Delhi, Delhi, India – 110060.
The latest financial statements of Translumina Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Translumina Therapeutics is 05AAGFT2436H1ZB, registered in Uttarakhand. The LLP has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAGFT2436H2Z6 (Delhi), 08AAGFT2436H1Z5 (Rajasthan).
Translumina Therapeutics operated in the healthcare industry, in the medical and laboratory equipment segment.
The peers of Translumina Therapeutics by revenue are Nipro India Corporation Private Limited, Trivitron Healthcare Private Limited, Wipro Ge Medical Device Manufacturing Private Limited, Meril Diagnostics Private Limited, Tarsons Products Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).